Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Home/Influenza/Immunogenicity and Safety Evaluation of QIS in Healthy Subjects

View on ClinicalTrials.gov

Completed

Back to Influenza trials

Immunogenicity and Safety Evaluation of QIS in Healthy Subjects

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Key details

Phase

Large-scale testing

Sponsor

Adimmune Corporation

Enrollment target

~174 participants

Started

December 2016

Primary completion

July 2017

Age range

3 Years – 17 Years

Last updated September 2019

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Immunogenicity and Safety Evaluation of QIS in Healthy Subjects — Stella